Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

GU Cancers 2018

2018 Genitourinary Cancers Symposium
San Francisco, CA, 8-10 February, 2018

The 2018 Genitourinary (GU) Cancers Symposium in San Francisco, CA was held on the 8-10 February. Here, international experts came together to showcase the latest groundbreaking research in genitourinary malignancies.

A few of the hot topics featured at the symposium included novel diagnostic tests, immune checkpoint inhibitors, addressing unmet needs in GU cancers and interesting updates on clinical trials, including POUT and PROSPER.

Watch our extensive range of coverage from the 2018 GU Cancers symposium below.

Prostate Cancer

View all
2:01
Case-based debate: is there evidence for local treatment in oligometastatic prostate cancer?
Adam Dicker • 9 Feb 2018
1:37
MRI-based prostate cancer diagnosis: economic and logistical considerations
Mark Emberton • 8 Feb 2018

Bladder Cancer

View all
2:06
A golden age for bladder cancer publications
Andrea Apolo • 9 Feb 2018
1:48
What does the 2-year follow-up tell us about the use of pembrolizumab for advanced bladder cancer?
Robert Jones • 8 Feb 2018

Diagnosis

View all
2:07
Differentiating aggressive vs. non-aggressive prostate cancer: the MiCheck GPC1 biomarker test
Neal Shore
0:57
MRI and MRI-directed biopsies for the diagnosis of prostate cancer
Mark Emberton • 8 Feb 2018

Treatment

View all
2:11
Treatment options for patients with bladder cancer, is bladder removal always necessary?
Alison Birtle • 9 Feb 2018
3:40
This is SPARTAN! Apalutamide treatment for nmCRPC
Eric Small • 8 Feb 2018
The content of VJOncology is intended for healthcare professionals